CDC Prevnar Guidance Will Urge Deferral Of Booster Dose During Shortage
Executive Summary
The Centers for Disease Control & Prevention will strengthen its recommendation that the booster dose of the pneumococcal conjugate vaccine (Wyeth's Prevnar) be delayed until supplies return to normal
You may also be interested in...
Wyeth/Amgen Enbrel Adds 25,000 Patients In Q1; Prevnar Back Orders Cleared
Improved supply for Wyeth/Amgen's Enbrel is allowing for the first significant increase in the number of patients on the TNF inhibitor in more than a year
Wyeth/Amgen Enbrel Adds 25,000 Patients In Q1; Prevnar Back Orders Cleared
Improved supply for Wyeth/Amgen's Enbrel is allowing for the first significant increase in the number of patients on the TNF inhibitor in more than a year
Wyeth Prevnar Capacity Expansion Planned For 2003; Shortage Until Then
Wyeth plans to add a second Prevnar production line during 2003 to help alleviate supply problems with the pneumococcal conjugate vaccine